1. Home
  2. RCKY vs TARA Comparison

RCKY vs TARA Comparison

Compare RCKY & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocky Brands Inc.

RCKY

Rocky Brands Inc.

HOLD

Current Price

$37.82

Market Cap

273.7M

ML Signal

HOLD

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

HOLD

Current Price

$4.17

Market Cap

269.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCKY
TARA
Founded
1932
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.7M
269.8M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
RCKY
TARA
Price
$37.82
$4.17
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$40.00
$24.40
AVG Volume (30 Days)
53.0K
712.9K
Earning Date
04-28-2026
05-01-2026
Dividend Yield
1.71%
N/A
EPS Growth
94.74
38.25
EPS
0.17
N/A
Revenue
$270,408,000.00
$2,948,000.00
Revenue This Year
$8.12
N/A
Revenue Next Year
$4.90
N/A
P/E Ratio
$219.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.69
$2.77
52 Week High
$48.70
$7.82

Technical Indicators

Market Signals
Indicator
RCKY
TARA
Relative Strength Index (RSI) 50.15 34.23
Support Level $37.31 $3.03
Resistance Level $44.83 $5.53
Average True Range (ATR) 1.50 0.29
MACD 0.34 -0.06
Stochastic Oscillator 66.93 2.93

Price Performance

Historical Comparison
RCKY
TARA

About RCKY Rocky Brands Inc.

Rocky Brands Inc is a designer, manufacturer, and marketer of premium footwear and apparel under brands such as Muck, XTRATUF, Rocky, Durango, Georgia Boot, Lehigh, Ranger, and the licensed brand Michelin. The company operates through three segments, with the wholesale segment generating the majority of revenue through sales of footwear and accessories to sporting goods stores, outdoor specialty stores, online retailers, marine stores, independent retailers, mass merchants, retail uniform stores, and specialty safety shoe stores. The retail segment focuses on direct-to-consumer sales through e-commerce platforms and company-operated stores, while the contract manufacturing segment includes sales to the U.S. military, private label production, and sourcing arrangements for customers.

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Share on Social Networks: